Company Data
Cognition Therapeutics Inc.
Ticker
CGTX
Current Price
$1.9125 4.51%
Market Cap
$140.5M
Price Target
Refer to Report
Volume
668.2K
52wk Range
$0.222301 - $3.83
Overview
Cognition Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the discovery and development of innovative, small molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system and retina. Its lead product candidate, CT1812, is an orally delivered, small molecule antagonist designed to penetrate the blood-brain barrier and bind selectively to the S2R complex.